Drug Shortage Report for NAROPIN

Last updated on 2021-09-14 History
Report ID 127239
Drug Identification Number 02229411
Brand name NAROPIN
Common or Proper name Naropin® (ropivacaine HCl 2mg/mL 5x200mL SU Polybag®)
Company Name ASPEN PHARMACARE CANADA INC.
Market Status MARKETED
Active Ingredient(s) ROPIVACAINE HYDROCHLORIDE
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration EPIDURAL BLOCK/INFILTRATION BLOCK/INFILTRATION EPIDURAL
Packaging size 5 PP Polybag
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2020-12-01
Actual start date 2020-12-02
Estimated end date 2021-12-31
Actual end date
Shortage status Actual shortage
Updated date 2021-09-14
Company comments VR89891CA1 Naropin® (ropivacaine HCl 2mg/mL 5x100mL SU Polybag®) is available as a replacement product PRODUCT CODE: VR89890CA1
Health Canada comments
Contact Address UNIT 8, 1155 NORTH SERVICE ROAD WEST
OAKVILLE, ONTARIO
CANADA L6M 3E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-10-27 English Compare
v2 2020-10-27 French Compare
v3 2020-10-27 English Compare
v4 2020-10-27 French Compare
v5 2020-10-27 English Compare
v6 2020-10-27 French Compare
v7 2020-12-02 English Compare
v8 2020-12-02 English Compare
v9 2020-12-02 French Compare
v10 2020-12-03 English Compare
v11 2021-02-12 English Compare
v12 2021-02-12 French Compare
v13 2021-09-03 English Compare
v14 2021-09-03 French Compare
v15 2021-09-14 English Compare
v16 2021-09-14 French Compare